Evogene(EVGN) Stock Price Today | Quotes & News

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

EVGN Evogene

Watchlist

1.3800
0.00000.00%

Close Mar 21 16:00 ET

9.38MMarket Cap-0.48P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

A. G. P. Maintains Evogene(EVGN.US) With Buy Rating, Cuts Target Price to $6
Moomoo NewsMar 7 07:31 ET · Ratings
Evogene Price Target Lowered to $6 From $11.25 at Alliance Global Partners
TipRanksMar 7 07:06 ET
Earnings Call Summary | Evogene(EVGN.US) Q4 2024 Earnings Conference
moomoo AIMar 6 12:51 ET · Conference Call
Lake Street Maintains Evogene(EVGN.US) With Buy Rating, Maintains Target Price $5
Moomoo NewsMar 6 09:31 ET · Ratings
Lake Street Keeps Their Buy Rating on Evogene (EVGN)
TipRanksMar 6 09:09 ET · Ratings
EVOGENE Earnings Results: $EVGN Reports Quarterly Earnings
Quiver QuantitativeMar 6 07:55 ET

Comments

Teddy123

Feb 13 21:05

AgPlenus Announces Discovery of a New Mode of Action for Fungicides Against Wheat Disease

$Evogene (EVGN.US)$
Revolutionary Discovery: New Weapon Against €1.2B Wheat Disease Threat Unveiled

Trytosaveabit

Nov 28, 2024 05:09

Update

$Evogene (EVGN.US)$ Reuters· 3 mins ago
Evogene Ltd: Unit Receives Notice of Termination of Licensing Agreement With Corteva for Bio Fungicide Lead Candidates

Jaguar8

Nov 19, 2024 20:02

NEWS

$Evogene (EVGN.US)$
Lavie Bio Advances its Bio-Fungicide LAV321, Targeting Downy Mildew, to Pre-Commercial Stage Following Successful 2024 Field Trial Results
LAV321demonstrated strong results in its third consecutive year of field trials in Europe
REHOVOT, Israel, Nov. 19, 2024 /PRNewswire/ -- Lavie Bio Ltd., a leading ag-biologicals company and subsidiary of Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), today announced significant progress in the development of its LAV321 bio-fungicide, targeti...